Myasthenia Gravis Treatment Market: Global Market Size, Forecast, Insights, Segmentation, and Competitive Landscape with Impact of COVID-19 & Russia-Ukraine War
The global myasthenia gravis treatment market is expected to grow at a CAGR of around 7.0% during 2025-2034. This report on global myasthenia gravis treatment market report provides holistic understanding of the market along with market sizing, forecast, drivers, challenges, and competitive landscape. The report presents a clear picture of the global myasthenia gravis treatment market by segmenting the market based on drug class, age group, end use and region. Also, detailed profiles of companies operating in the myasthenia gravis treatment market are provided in this report. We believe that this report will aid the professionals and industry stakeholders in making informed decision.
Market Drivers
• Growing Awareness
• Expanding Government Initiatives
Market Challenges
• Associated Side Effects
Historical & Forecast Period
Base Year: 2024
Historical Period: 2020-2024
Forecast Period: 2025-2034
Market by Drug Class
• Intravenous Immunoglobulin
• Monoclonal Antibodies
• Cholinesterase Inhibitors
• Other Drugs
Market by Age Group
• Below 55 Years
• Above 55 Years
Market by End-Use
• Hospital Pharmacies
• Drug Store and Retail Pharmacies
• Online Providers
Market by Region
• Europe
Germany
United Kingdom
France
Italy
Spain
Russia
Netherlands
Rest of Europe
• North America
United States
Canada
• Asia Pacific
China
Japan
India
South Korea
Australia
Indonesia
Rest of Asia Pacific
• Latin America
Mexico
Brazil
Argentina
Rest of Latin America
• Middle East & Africa
Saudi Arabia
Turkey
Iran
United Arab Emirates
Rest of Middle East & Africa
- 1. Preface
- 1.1 Objective
- 1.2 Target Audience & Key Offerings
- 1.3 Report’s Scope
- 1.4 Research Methodology
- 1.4.1 Phase I
- 1.4.2 Phase II
- 1.4.3 Phase III
- 1.5 Assumptions
- 2. Key Insights
- 3. Global Myasthenia Gravis Treatment Market
- 3.1. Introduction
- 3.2. Market Drivers
- 3.3. Market Challenges
- 4. Global Myasthenia Gravis Treatment Market Analysis
- 4.1. Market Portraiture
- 4.2. Market Drug Class
- 4.3. Market Forecast
- 4.4. Impact of COVID-19
- 4.5. Impact of Russia-Ukraine War
- 5. Global Myasthenia Gravis Treatment Market by Drug Class
- 5.1. Introduction
- 5.2. Intravenous Immunoglobulin
- 5.3. Monoclonal Antibodies
- 5.4. Cholinesterase Inhibitors
- 5.5. Other Drugs
- 6. Global Myasthenia Gravis Treatment Market by Age Group
- 6.1. Introduction
- 6.2. Below 55 Years
- 6.3. Above 55 Years
- 7. Global Myasthenia Gravis Treatment Market by End-Use
- 7.1. Introduction
- 7.2. Hospital Pharmacies
- 7.3. Drug Store and Retail Pharmacies
- 7.4. Online Providers
- 8. Global Myasthenia Gravis Treatment Market by Region
- 8.1. Introduction
- 8.2. Europe
- 8.2.1. Germany
- 8.2.2. United Kingdom
- 8.2.3. France
- 8.2.4. Italy
- 8.2.5. Spain
- 8.2.6. Russia
- 8.2.7. Netherlands
- 8.2.8. Rest of the Europe
- 8.3. North America
- 8.3.1. United States
- 8.3.2. Canada
- 8.4. Asia Pacific
- 8.4.1. China
- 8.4.2. Japan
- 8.4.3. India
- 8.4.4. South Korea
- 8.4.5. Australia
- 8.4.6. Indonesia
- 8.4.7. Rest of the Asia Pacific
- 8.5. Latin America
- 8.5.1. Mexico
- 8.5.2. Brazil
- 8.5.3. Argentina
- 8.5.4. Rest of Latin America
- 8.6. Middle East & Africa
- 8.6.1. Saudi Arabia
- 8.6.2. Turkey
- 8.6.3. Iran
- 8.6.4. United Arab Emirates
- 8.6.5. Rest of Middle East & Africa
- 9. SWOT Analysis
- 10. Porter’s Five Forces
- 11. Market Value Chain Analysis
- 12. Competitive Landscape
- 12.1. Competitive Scenario
- 12.2. Company Profiles
- 12.2.1. Astellas Pharma Inc.
- 12.2.2. AstraZeneca
- 12.2.3. Bausch Health Companies, Inc.
- 12.2.4. CSL Limited
- 12.2.5. F. Hoffmann-La Roche Ltd.
- 12.2.6. Grifols, S.A.
- 12.2.7. Kedrion, SpA
- 12.2.8. Novartis AG
- 12.2.9. Octapharma AG
- 12.2.10. Stryker Corporation
- 12.2.11. Veloxis Pharmaceuticals Inc.
- 12.2.12. Zydus Lifesciences Limited
- List of Figures
- Figure 1: Global Myasthenia Gravis Treatment Market (in US$ Million), 2020-2024
- Figure 2: Global Myasthenia Gravis Treatment Market by Drug Class, 2024
- Figure 3: Global Myasthenia Gravis Treatment Market by Age Group, 2024
- Figure 4: Global Myasthenia Gravis Treatment Market by End-Use, 2024
- Figure 5: Global Myasthenia Gravis Treatment Market by Region, 2024
- Figure 6: Global Myasthenia Gravis Treatment Market (in US$ Million), 2025-2034
- Figure 7: Global Myasthenia Gravis Treatment Market by Drug Class (in %), 2024 & 2034
- Figure 8: Global Intravenous Immunoglobulin Myasthenia Gravis Treatment Market (in US$ Million), 2020-2024
- Figure 9: Global Intravenous Immunoglobulin Myasthenia Gravis Treatment Market (in US$ Million), 2025-2034
- Figure 10: Global Monoclonal Antibodies Myasthenia Gravis Treatment Market (in US$ Million), 2020-2024
- Figure 11: Global Monoclonal Antibodies Myasthenia Gravis Treatment Market (in US$ Million), 2025-2034
- Figure 12: Global Cholinesterase Inhibitors Myasthenia Gravis Treatment Market (in US$ Million), 2020-2024
- Figure 13: Global Cholinesterase Inhibitors Myasthenia Gravis Treatment Market (in US$ Million), 2025-2034
- Figure 14: Global Other Drugs Myasthenia Gravis Treatment Market (in US$ Million), 2020-2024
- Figure 15: Global Other Drugs Myasthenia Gravis Treatment Market (in US$ Million), 2025-2034
- Figure 16: Global Myasthenia Gravis Treatment Market by Age Group (in %), 2024 & 2034
- Figure 17: Global Below 55 Years Myasthenia Gravis Treatment Market (in US$ Million), 2020-2024
- Figure 18: Global Below 55 Years Myasthenia Gravis Treatment Market (in US$ Million), 2025-2034
- Figure 19: Global Above 55 Years Myasthenia Gravis Treatment Market (in US$ Million), 2020-2024
- Figure 20: Global Above 55 Years Myasthenia Gravis Treatment Market (in US$ Million), 2025-2034
- Figure 21: Global Myasthenia Gravis Treatment Market by End-Use (in %), 2024 & 2034
- Figure 22: Global Hospital Pharmacies Myasthenia Gravis Treatment Market (in US$ Million), 2020-2024
- Figure 23: Global Hospital Pharmacies Myasthenia Gravis Treatment Market (in US$ Million), 2025-2034
- Figure 24: Global Drug Store and Retail Pharmacies Myasthenia Gravis Treatment Market (in US$ Million), 2020-2024
- Figure 25: Global Drug Store and Retail Pharmacies Myasthenia Gravis Treatment Market (in US$ Million), 2025-2034
- Figure 26: Global Online Providers Myasthenia Gravis Treatment Market (in US$ Million), 2020-2024
- Figure 27: Global Online Providers Myasthenia Gravis Treatment Market (in US$ Million), 2025-2034
- Figure 28: Global Myasthenia Gravis Treatment Market by Region (in %), 2024 & 2034
- Figure 29: Europe Myasthenia Gravis Treatment Market (in US$ Million), 2020-2024
- Figure 30: Europe Myasthenia Gravis Treatment Market (in US$ Million), 2025-2034
- Figure 31: Europe Myasthenia Gravis Treatment Market by Country (in %), 2024 & 2034
- Figure 32: Germany Myasthenia Gravis Treatment Market (in US$ Million), 2020-2034
- Figure 33: United Kingdom Myasthenia Gravis Treatment Market (in US$ Million), 2020-2034
- Figure 34: France Myasthenia Gravis Treatment Market (in US$ Million), 2020-2034
- Figure 35: Italy Myasthenia Gravis Treatment Market (in US$ Million), 2020-2034
- Figure 36: Spain Myasthenia Gravis Treatment Market (in US$ Million), 2020-2034
- Figure 37: Russia Myasthenia Gravis Treatment Market (in US$ Million), 2020-2034
- Figure 38: Netherlands Myasthenia Gravis Treatment Market (in US$ Million), 2020-2034
- Figure 39: North America Myasthenia Gravis Treatment Market (in US$ Million), 2020-2024
- Figure 40: North America Myasthenia Gravis Treatment Market (in US$ Million), 2025-2034
- Figure 41: North America Myasthenia Gravis Treatment Market by Country (in %), 2024 & 2034
- Figure 42: United States Myasthenia Gravis Treatment Market (in US$ Million), 2020-2034
- Figure 43: Canada Myasthenia Gravis Treatment Market (in US$ Million), 2020-2034
- Figure 44: Asia Pacific Myasthenia Gravis Treatment Market (in US$ Million), 2020-2024
- Figure 45: Asia Pacific Myasthenia Gravis Treatment Market (in US$ Million), 2025-2034
- Figure 46: Asia Pacific Myasthenia Gravis Treatment Market by Country (in %), 2024 & 2034
- Figure 47: China Myasthenia Gravis Treatment Market (in US$ Million), 2020-2034
- Figure 48: Japan Myasthenia Gravis Treatment Market (in US$ Million), 2020-2034
- Figure 49: India Myasthenia Gravis Treatment Market (in US$ Million), 2020-2034
- Figure 50: South Korea Myasthenia Gravis Treatment Market (in US$ Million), 2020-2034
- Figure 51: Australia Myasthenia Gravis Treatment Market (in US$ Million), 2020-2034
- Figure 52: Indonesia Myasthenia Gravis Treatment Market (in US$ Million), 2020-2034
- Figure 53: Latin America Myasthenia Gravis Treatment Market (in US$ Million), 2020-2024
- Figure 54: Latin America Myasthenia Gravis Treatment Market (in US$ Million), 2025-2034
- Figure 55: Latin America Myasthenia Gravis Treatment Market by Country (in %), 2024 & 2034
- Figure 56: Mexico Myasthenia Gravis Treatment Market (in US$ Million), 2020-2034
- Figure 57: Brazil Myasthenia Gravis Treatment Market (in US$ Million), 2020-2034
- Figure 58: Argentina Myasthenia Gravis Treatment Market (in US$ Million), 2020-2034
- Figure 59: Middle East & Africa Myasthenia Gravis Treatment Market (in US$ Million), 2020-2024
- Figure 60: Middle East & Africa Myasthenia Gravis Treatment Market (in US$ Million), 2025-2034
- Figure 61: Middle East & Africa Myasthenia Gravis Treatment Market by Country (in %), 2024 & 2034
- Figure 62: Saudi Arabia Myasthenia Gravis Treatment Market (in US$ Million), 2020-2034
- Figure 63: Turkey Myasthenia Gravis Treatment Market (in US$ Million), 2020-2034
- Figure 64: Iran Myasthenia Gravis Treatment Market (in US$ Million), 2020-2034
- Figure 65: UAE Myasthenia Gravis Treatment Market (in US$ Million), 2020-2034
- Figure 66: Market Value Chain
- List of Tables
- Table 1: Global Myasthenia Gravis Treatment Market Portraiture
- Table 2: Global Myasthenia Gravis Treatment Market by Drug Class (in US$ Million), 2024 & 2034
- Table 3: Global Myasthenia Gravis Treatment Market by Age Group (in US$ Million), 2024 & 2034
- Table 4: Global Myasthenia Gravis Treatment Market by End-Use (in US$ Million), 2024 & 2034
- Table 5: Global Myasthenia Gravis Treatment Market by Region (in US$ Million), 2024 & 2034
- Table 6: Europe Myasthenia Gravis Treatment Market by Country (in US$ Million), 2024 & 2034
- Table 7: North America Myasthenia Gravis Treatment Market by Country (in US$ Million), 2024 & 2034
- Table 8: Asia Pacific Myasthenia Gravis Treatment Market by Country (in US$ Million), 2024 & 2034
- Table 9: Latin America Myasthenia Gravis Treatment Market by Country (in US$ Million), 2024 & 2034
- Table 10: Middle East & Africa Myasthenia Gravis Treatment Market by Country (in US$ Million),
- 2024 & 2034
- Table 11: List of Key Players
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook